Ortho Clinical Diagnostics, one of the world's largest pure-play in vitro diagnostics companies, has announced the launch of the first quantitative COVID-19 IgG antibody test in addition to a total COVID-19 nucleocapsid antibody test.
calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which
gives clinicians and public health leaders a standard tool to measure antibody response to SARS-CoV-2
RARITAN, N.J., May 21, 2021 /CNW/ Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world s largest pure-play in vitro diagnostics companies, today announced the launch of the first quantitative COVID-19 IgG antibody test in addition to a total COVID-19 nucleocapsid antibody test.
Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test. Both tests help health care teams differentiate the cause of antibodies against SARS-CoV-2 and are processed on Ortho s trusted VITROS
06 May 2021 (Last Updated May 6th, 2021 12:37)
Ortho Clinical Diagnostics has received CE mark for the new VITROS Anti-SARS-CoV-2 IgG Quantitative (QN) Antibody assay designed to offer values in line with the World Health Organisation (WHO) International Standard.
Share Article
The company intends to produce up to eight million quantitative IgG antibody tests monthly. Credit: Andreas Lischka from Pixabay.
The WHO standardisation aids in regulating Covid-19 virus serological methods and permits unified data comparison across labs.
The new assay is indicated for the qualitative and quantitative identification of IgG antibodies to SARS-CoV-2 in human serum and plasma.
The test will facilitate analysis of a person’s immune response level on being infected with the SARS-CoV-2 virus or on receiving a vaccination. It will serve as a standardised tool for public health workers to assess changes in the antibody levels of Covid-19 patient
Share this article
- Ortho s VITROS
® Anti-SARS-CoV-2 IgG Quantitative Antibody test is traceable to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which is developed to facilitate the standardization of SARS-CoV-2 serological methods
-
The test gives clinicians and public health leaders a standard tool to evaluate immune response after infection or vaccination
RARITAN, N.J., May 5, 2021 /PRNewswire/ Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world s largest pure-play in vitro diagnostics companies, today announced its quantitative COVID-19 IgG antibody test achieved CE Mark.
Ortho s new VITROS
® Anti-SARS-CoV-2 IgG Quantitative (QN) Antibody assay provides numerical values traceable to the World Health Organization (WHO) International Standard,
Ortho Clinical Diagnostics Recognized With Prestigious Edison Award for Highly Accurate COVID-19 Solutions Capable of Mass-Scale Testing finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.